Systematic construction of a conceptual minimal model of plasma cholesterol levels based on knockout mouse phenotypes.

Elevated plasma cholesterol, a well-known risk factor for cardiovascular diseases, is the result of the activity of many genes and their encoded proteins in a complex physiological network. We aim to develop a minimal kinetic computational model for predicting plasma cholesterol levels. To define the scope of this model, it is essential to discriminate between important and less important processes influencing plasma cholesterol levels. To this end, we performed a systematic review of mouse knockout strains and used the resulting dataset, named KOMDIP, for the identification of key genes that determine plasma cholesterol levels. Based on the described phenotype of mouse knockout models, 36 of the 120 evaluated genes were marked as key genes that have a pronounced effect on the plasma cholesterol concentration. The key genes include well-known genes, e.g., Apoe and Ldlr, as well as genes hardly linked to cholesterol metabolism so far, e.g., Plagl2 and Slc37a4. Based on the catalytic function of the genes, a minimal conceptual model was defined. A comparison with nine conceptual models from literature revealed that each of the individual published models is less complete than our model. Concluding, we have developed a conceptual model that can be used to develop a physiologically based kinetic model to quantitatively predict plasma cholesterol levels.

[1]  Robert L. Hamilton,et al.  Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice , 2000, Nature Medicine.

[2]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[3]  A. Lusis.  Genetic factors affecting blood lipoproteins: the candidate gene approach. , 1988, Journal of lipid research.

[4]  R. Hammer,et al.  Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice. , 2006, The Journal of clinical investigation.

[5]  J. Brady,et al.  Analysis of Glomerulosclerosis and Atherosclerosis in Lecithin Cholesterol Acyltransferase-deficient Mice* , 2001, The Journal of Biological Chemistry.

[6]  A. Tall,et al.  Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. Shimano,et al.  Early Embryonic Lethality Caused by Targeted Disruption of the 3-Hydroxy-3-methylglutaryl-CoA Reductase Gene* , 2003, Journal of Biological Chemistry.

[8]  A. Gebre,et al.  Effect of apolipoprotein A-I deficiency on lecithin:cholesterol acyltransferase activation in mouse plasma. , 1995, Journal of lipid research.

[9]  D. Russell,et al.  Alternate pathways of bile acid synthesis in the cholesterol 7alpha-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding. , 2001, Journal of lipid research.

[10]  Judith A. Blake,et al.  The mouse genome database (MGD): new features facilitating a model system , 2006, Nucleic Acids Res..

[11]  Albert K Groen,et al.  Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. , 2006, The Journal of clinical investigation.

[12]  John Quackenbush.  Microarray data normalization and transformation , 2002, Nature Genetics.

[13]  T. Suda,et al.  Angiopoietin-related growth factor antagonizes obesity and insulin resistance , 2005, Nature Medicine.

[14]  P. Pajukanta,et al.  A treasure trove for lipoprotein biology , 2008, Nature Genetics.

[15]  I. Tabas.  Cholesterol in health and disease. , 2002, The Journal of clinical investigation.

[16]  K. Svenson,et al.  Multiple trait measurements in 43 inbred mouse strains capture the phenotypic diversity characteristic of human populations. , 2007, Journal of applied physiology.

[17]  J. Manis,et al.  Knock out, knock in, knock down--genetically manipulated mice and the Nobel Prize. , 2007, The New England journal of medicine.

[18]  A. Tall,et al.  Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. , 1999, The Journal of clinical investigation.

[19]  Hugo Vanderstichele,et al.  Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.

[20]  M. G. Cusella De Angelis,et al.  Disruption of the gene encoding 3β‐hydroxysterol Δ14‐reductase (Tm7sf2) in mice does not impair cholesterol biosynthesis , 2008, The FEBS journal.

[21]  J. Schneider,et al.  "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. , 2005, Cell metabolism.

[22]  Jerrold M. Ward,et al.  Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis , 2001, Molecular and Cellular Biology.

[23]  G. Duchateau,et al.  Reduction of cholesterol absorption by dietary plant sterols and stanols in mice is independent of the Abcg5/8 transporter. , 2006, The Journal of nutrition.

[24]  A. Hunter,et al.  Lathosterolosis: an inborn error of human and murine cholesterol synthesis due to lathosterol 5-desaturase deficiency. , 2003, Human molecular genetics.

[25]  S. Young,et al.  Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Jonathan C. Cohen,et al.  Normal Sorting but Defective Endocytosis of the Low Density Lipoprotein Receptor in Mice with Autosomal Recessive Hypercholesterolemia* , 2003, Journal of Biological Chemistry.

[27]  C. Fraser,et al.  Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. , 2005, Endocrinology.

[28]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[29]  M. Cybulsky,et al.  A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. , 2001, The Journal of clinical investigation.

[30]  C. Gabel,et al.  High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. McLeod,et al.  Adipocyte Enhancer‐Binding Protein 1 Modulates Adiposity and Energy Homeostasis , 2007, Obesity.

[32]  Robert V Farese,et al.  Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Nishikawa,et al.  Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIα , 1999, Oncogene.

[34]  Robert V Farese,et al.  Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Dietschy,et al.  Cholesterol metabolism in the brain , 2001, Current opinion in lipidology.

[36]  P. Einat,et al.  Generation of Viable Cholesterol-Free Mice , 2003, Science.

[37]  J. Ward,et al.  Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter. , 2003, Human molecular genetics.

[38]  Robert V Farese,et al.  Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[40]  F. F. Weight,et al.  Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith--Lemli--Opitz syndrome. , 2001, Human molecular genetics.

[41]  C. Shoulders,et al.  Genetics of familial combined hyperlipidemia and risk of coronary heart disease. , 2004, Human molecular genetics.

[42]  C. Fielding,et al.  Molecular physiology of reverse cholesterol transport. , 1995, Journal of lipid research.

[43]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Zechner,et al.  Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. , 1995, The Journal of clinical investigation.

[45]  David S Wishart,et al.  Computational systems biology in drug discovery and development: methods and applications. , 2007, Drug discovery today.

[46]  R. Shivdasani,et al.  Loss of the PlagL2 transcription factor affects lacteal uptake of chylomicrons. , 2007, Cell metabolism.

[47]  M. Yaniv,et al.  Hepatocyte Nuclear Factor 1 Inactivation Results in Hepatic Dysfunction, Phenylketonuria, and Renal Fanconi Syndrome , 1996, Cell.

[48]  P. Chuang,et al.  Mouse dispatched mutants fail to distribute hedgehog proteins and are defective in hedgehog signaling , 2002, Development.

[49]  S. Perrey,et al.  Embryonic Lethality and Defective Neural Tube Closure in Mice Lacking Squalene Synthase* , 1999, The Journal of Biological Chemistry.

[50]  S. Young,et al.  Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. , 2007, Cell metabolism.

[51]  Luquan Wang,et al.  Materials and Methods Figs. S1 to S4 Tables S1 and S2 References Niemann-pick C1 like 1 Protein Is Critical for Intestinal Cholesterol Absorption , 2022 .

[52]  D. Rader.  A new feature on the cholesterol-lowering landscape , 2001, Nature Medicine.

[53]  D K Burns,et al.  Defective forebrain development in mice lacking gp330/megalin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[54]  C. Chiang,et al.  Cholesterol modification restricts the spread of Shh gradient in the limb bud. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Dietschy,et al.  Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. , 1993, Annual review of nutrition.

[56]  J. Dietschy,et al.  Control of Cholesterol Turnover in the Mouse* , 2002, The Journal of Biological Chemistry.

[57]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[58]  C. Ballantyne,et al.  Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[59]  C. Devlin,et al.  Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. K. Oeser,et al.  Deletion of the Gene Encoding the Ubiquitously Expressed Glucose-6-phosphatase Catalytic Subunit-related Protein (UGRP)/Glucose-6-phosphatase Catalytic Subunit-β Results in Lowered Plasma Cholesterol and Elevated Glucagon* , 2006, Journal of Biological Chemistry.

[61]  R. Xavier,et al.  ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerols⃞ Published, JLR Papers in Press, December 1, 2006. , 2007, Journal of Lipid Research.

[62]  Daniel J. Rader,et al.  Translating molecular discoveries into new therapies for atherosclerosis , 2008, Nature.

[63]  D. Lauffenburger,et al.  Applying computational modeling to drug discovery and development. , 2006, Drug discovery today.

[64]  W. Wetsel,et al.  Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[65]  L. Lagrost,et al.  Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer proteins⃞ Published, JLR Papers in Press, October 19, 2006. , 2007, Journal of Lipid Research.

[66]  Liping Zhao,et al.  The roles of circulating high-density lipoproteins and trophic hormones in the phenotype of knockout mice lacking the steroidogenic acute regulatory protein. , 2002, Molecular endocrinology.

[67]  M. Hojjati,et al.  Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice. , 2005, Biochimica et biophysica acta.

[68]  J. Gustafsson,et al.  Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. , 2001, The Journal of clinical investigation.

[69]  H. Kiyokawa,et al.  Prolactin receptor-associated protein/17beta-hydroxysteroid dehydrogenase type 7 gene (Hsd17b7) plays a crucial role in embryonic development and fetal survival. , 2008, Molecular endocrinology.

[70]  H. Waterham.  Defects of cholesterol biosynthesis , 2006, FEBS letters.

[71]  Steven W. Martin,et al.  The role of mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modelling in translational research of biologics. , 2007, Drug discovery today.